...
...
×
Scenario Tabs
In this scenario, you are a pharmacist working in the community. You are tasked with counselling a patient who has come in to discuss their current weight loss plan. The student must provide appropriate advice, answering any questions they have.
Please ensure that this scenario and mark scheme align with the most up-to-date guidelines from the UK NICE and the BNF when using it for your OSCE assessment.
You will need a student pharmacist and an actor for this OSCE station.
Obesity
Weight-loss medication
You are a pharmacist in a community pharmacy. You have been asked to counsel a patient. The patient is a 38-year-old female who is seeking advice about her current weight loss management.
To do:
You are expected to explore the patient’s current concerns, expectations and symptoms.
Provide counselling information to this patient and answer any questions appropriately. You must provide relevant advice.
You have 10 minutes.
You have access to the BNF.
You have access to a Patient Information Leaflet for Mounjaro®. https://www.medicines.org.uk/emc/files/pil.15481.pdf
You have access to a Patient Information Leaflet for Wegovy®. https://www.medicines.org.uk/emc/files/pil.13800.pdf
You are Layla Hussain (LAY-lah HOO-sane)
Opening Statement:
“Hi… I’ve been using Wegovy® for a while now but I’m still really struggling with the side effects. I wanted to ask if I can switch to Mounjaro® instead.”
Main concerns:
“I’ve been on Wegovy® for just over four months now. My starting weight was 104 kilos, and now I’m around 101 kilos… so only about 3 kilos down.”
“My BMI was around 37 when I started, and it’s still around 36 now.”
“I know some people lose a lot more by this point, so it’s frustrating.”
“I’m on the highest dose now, but the side-effects are getting awful”
“My friend switched to Mounjaro® and said it works much better for her.”
Symptoms:
“I feel sick most days but I’ve not actually thrown up.”
“My stomach feels bloated and crampy.”
“I keep having diarrhoea, it’s been on and off for a few weeks.”
“I also keep getting headaches.”
“No severe tummy pain.”
“No blood in stool.”
Dehydration screen
“No, I've not had a dry tongue or confusion.”
“No I’ve not been feeling faint or dizzy”
Medication History:
“I have polycystic ovary syndrome.”
“I have high blood pressure.”
“I’ve had asthma since childhood.”
Past Medical History:
“I take Wegovy® (semaglutide) 2.4 mg once a week.”
“I take a 5mg amlodipine tablet every morning.”
“I use my salbutamol inhaler when I get wheezy.”
Allergies:
“I don't have any allergies”
Lifestyle Factors/Social History:
“I work full-time in IT so I’m sitting down most of the day.”
Diet:
“I used to skip breakfast completely, but now I try to have something small like yoghurt or fruit.”
“I’ve cut down on snacking at work - I still do it sometimes, but not as much.”
“I’m trying to cook more at home… we’ve reduced takeaway nights to once a week.”
“I’ve started going on short walks - maybe 10 to 15 minutes - three or four times a week. I’m struggling with motivation.”
“I don’t drink alcohol.”
“I don’t smoke.”
Questions to ask:
Why am I not losing weight?
Is there anything I could do to improve my side effects?
If I stop the Wegovy®, can I start Mounjaro® straight away?
I was already on the maximum dose for Wegovy®, can I just start Mounjaro® on the same dose?
Achieving at least 50% OR missing specific required marks.
Have you heard of Nuumad before?
Understanding how Nuumad help patients?
Recommend Nuumad to patients?
Consider using Nuumad yourself?
More resources about Nuumad?
Response saved.
Referral criteria for patients on Wegovy® / Mounjaro®:
Severe, continuous abdominal pain, particularly if radiating to the back (suspected acute pancreatitis)
Persistent vomiting with inability to retain fluids and signs of severe dehydration
Blood in vomit or stools
Loss of consciousness or seizure
Ongoing nausea, vomiting or diarrhoea that may lead to dehydration but the patient can still tolerate some fluids
New or worsening visual symptoms in a patient with diabetes (possible worsening diabetic retinopathy)
Recurrent symptoms suggestive of hypoglycaemia in patients on insulin or sulfonylureas
Persistent abdominal discomfort not severe enough for A&E review
Side effects significantly affecting daily functioning despite lifestyle management strategies
NICE, 2025. Overweight and obesity: identification, assessment and management (NG246). [online] Available at: https://cks.nice.org.uk/topics/obesity/ [Accessed 30 November 2025].
NHS England, Digital Weight Management Programme. [online] Available at: https://www.england.nhs.uk/digital-weight-management/ [Accessed 1 December 2025].
NHS England, Weight management injections. [online] Available at: https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/#tirzepatide [Accessed 30 November 2025].
Nuumad Weight Loss Training